ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Duke Comprehensive Cancer Center


Include trials that are no longer recruiting patients.

48 studies were found.
1.No longer recruitingAntiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
Conditions: AIDS-related peripheral/systemic lymphoma; HIV-associated Hodgkin's disease; recurrent adult acute lymphocytic leukemia; ...
2.No longer recruitingBiological Therapy in Treating Patients With Advanced Cancer
Conditions: stage III gastric cancer; stage IIIB breast cancer; stage II gastric cancer; stage IIIA breast cancer; stage III ovarian epithelial cancer; ...
3.No longer recruitingBiological Therapy in Treating Patients With Metastatic Cancer
Conditions: Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
4.No longer recruitingBiological Therapy in Treating Patients With Stage I, Stage II, or Stage III Pancreatic Cancer That Has Been Surgically Removed
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
5.No longer recruitingCarboplatin in Patients With Progressive Gliomas
Conditions: recurrent childhood brain stem glioma; recurrent childhood visual pathway glioma; recurrent childhood cerebral astrocytoma; ...
6.No longer recruitingCarmustine and O6-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Condition: adult glioblastoma multiforme
7.No longer recruitingCarmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
Conditions: recurrent adult brain tumor; adult brain stem glioma; adult noninfiltrating astrocytoma; ...
8.No longer recruitingCarmustine Plus O(6)-benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma
9.CompletedCarmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
10.CompletedCarmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult brain stem glioma; Mixed Gliomas
11.RecruitingCelecoxib and Gefitinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
12.No longer recruitingChemotherapy in Treating Patients With Recurrent Malignant Glioma
Condition: recurrent adult brain tumor
13.RecruitingCisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
Condition: Cervical Cancer
14.No longer recruitingComparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer
Conditions: Colon Cancer; Rectal Cancer
15.No longer recruitingDiet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer
Conditions: Nutrition; Quality of Life; stage I prostate cancer; stage II prostate cancer
16.RecruitingEF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
17.RecruitingEF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
18.CompletedFlt3L in Treating Patients With Metastatic Colorectal Cancer
Conditions: liver metastases; lung metastases; stage IV colon cancer
19.No longer recruitingGenetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
Conditions: Lymphoma; Brain Tumor
20.RecruitingHyperthermia, Radiation Therapy, Surgery, and Optional Chemotherapy in Treating Patients With Soft Tissue Sarcoma of the Limbs
Conditions: stage I adult soft tissue sarcoma; stage II adult soft tissue sarcoma; stage III adult soft tissue sarcoma; stage IV adult soft tissue sarcoma
21.No longer recruitingImmunotherapy in Treating Patients With Metastatic Breast Cancer
Condition: stage IV breast cancer
22.CompletedImmunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer
Conditions: liver metastases; stage IV colon cancer
23.SuspendedIntrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
Condition: leptomeningeal metastases
24.CompletedIrinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; Mixed Gliomas
25.No longer recruitingMelphalan in Patients With Neoplastic Meningitis
Conditions: Lymphoma; Leukemia; Brain Tumor
26.No longer recruitingMonoclonal Antibody Therapy in Patients With Primary or Metastatic Brain Tumors
Conditions: Astrocytoma; Brain Tumor; Oligodendroglioma; Glioblastoma Multiforme; Glioma
27.No longer recruitingMonoclonal Antibody Therapy in Treating Patients With Brain Metastases
Condition: leptomeningeal metastases
28.No longer recruitingMonoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas
Conditions: Ependymoma; Astrocytoma; Brain Tumor; Oligodendroglioma; Neuroectodermal Tumors, Primitive; Glioblastoma; Gliomas
29.RecruitingPeripheral Stem Cell Transplantation Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma
Conditions: Breast Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; skin tumor
30.No longer recruitingRadiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
Conditions: Central Nervous System Tumor; Brain Tumor
31.RecruitingRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
Condition: adult brain tumor
32.CompletedRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Condition: Brain Tumor
33.SuspendedRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Conditions: adult brain tumor; brain metastases; localized resectable neuroblastoma; Neuroblastoma
34.RecruitingA Safety and Feasibility Study of Active Immunotherapy in Patients with Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed with Antigen Encoded in Amplified Autologous Tumor RNA
Condition: Prostate Cancer
35.No longer recruitingStudy of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage I prostate cancer; stage II prostate cancer; Fatigue; Nutrition; psychosocial effects/treatment; ...
36.No longer recruitingTemozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult well-differentiated oligodendroglioma; ...
37.No longer recruitingTemozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
Conditions: childhood brain tumor; childhood nerve tumor
38.CompletedTemozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
Condition: Glioblastoma
39.No longer recruitingTemozolomide in Treating Patients With Anaplastic Oligodendroglioma
Conditions: adult anaplastic oligodendroglioma; recurrent adult brain tumor
40.No longer recruitingTemozolomide in Treating Patients With Brain Metastases
Condition: brain metastases
41.RecruitingTemozolomide in Treating Patients With Progressive Low-Grade Glioma
Conditions: adult brain tumor; childhood brain stem glioma; Childhood Cerebral Astrocytoma; childhood visual pathway and hypothalamic glioma; ...
42.RecruitingTemozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
Condition: Cancer
43.RecruitingVaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
44.CompletedVaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal
Conditions: Stage IV Melanoma; Recurrent Melanoma
45.No longer recruitingVaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate
46.RecruitingVaccine Therapy in Treating Patients With Refractory Stage IV Cancer
Condition: unspecified adult solid tumor, protocol specific
47.No longer recruitingVaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer
48.No longer recruitingZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act